N-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for Psychopathology

International Journal of Neuropsychopharmacology

Volumn 19, Issue 12, 2016, Pages

  Pusceddu, Matteo M ^a   Kelly, Philip ^b   Stanton, Catherine ^b   Cryan, John F ^c   Dinan, Timothy G ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b TEAGASC   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Alzheimer's disease; Bipolar disorder; Depression; Omega 3 polyunsaturated fatty acids (n 3 PUFAs); Schizophrenia

Indexed keywords

AMYLOID BETA PROTEIN; APOPTOSIS INHIBITOR; BRAIN DERIVED NEUROTROPHIC FACTOR; OMEGA 3 FATTY ACID;

ADOLESCENCE; ADULTHOOD; ALZHEIMER DISEASE; BIPOLAR DISORDER; CHILDHOOD DISEASE; DIETARY INTAKE; EMBRYO DEVELOPMENT; GERIATRIC PATIENT; GLUTAMATERGIC SYNAPSE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFORMATION RETRIEVAL; INTESTINE FLORA; LIFESPAN; MAJOR DEPRESSION; MEDLINE; MENTAL DISEASE; MONOAMINERGIC SYSTEM; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SCHIZOPHRENIA; STRESS; AGE; AGING; ANIMAL; BRAIN; COGNITION; DRUG EFFECTS; FEEDING BEHAVIOR; MENTAL HEALTH; METABOLISM; PATHOPHYSIOLOGY; PROTECTION; PSYCHOLOGY; RISK FACTOR;

AGE FACTORS; AGING; ANIMALS; BRAIN; COGNITION; FATTY ACIDS, OMEGA-3; FEEDING BEHAVIOR; HUMANS; MENTAL DISORDERS; MENTAL HEALTH; PROTECTIVE FACTORS; RISK FACTORS;

EID: 85012203044     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyw078     Document Type: Review

References (186)

1. Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, Hwang DR, Keilp J, Kochan L, Van Heertum R, Gorman JM, Laruelle M. (2002) Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci 22:3708-3719.
2. Amminger GP, Berger GE, Schafer MR, Klier C, Friedrich MH, Feucht M. (2007) Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry 61:551-553.
3. Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, Mackinnon A, McGorry PD, Berger G.E. (2010) Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 67:146-154.
4. Antypa N, Van der Does AJ, Smelt AH, Rogers RD (2009) Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers. J Psychopharmacol 23:831-840.
5. Barcelo-Coblijn G, Murphy E.J. (2009) Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog Lipid Res 48:355-374.
6. Barnes J, Mondelli V, Pariante C.M. (2016) NPPR: genetic contributions of inflammation to depression. Neuropsychopharmacology. Advance online publication. doi:10.1038/npp.2016.169.
7. Baumgartner J, Smuts CM, Malan L, Kvalsvig J, van Stuijvenberg ME, Hurrell RF, Zimmermann M.B. (2012) Effects of iron and n-3 fatty acid supplementation, alone and in combination, on cognition in school children: a randomized, double-blind, placebo-controlled intervention in South Africa. Am J Clin Nutr 96:1327-1338.
8. Baxter AJ, Patton G, Scott KM, Degenhardt L, Whiteford H.A. (2013) Global epidemiology of mental disorders: what are we missing? PLoS One 8:e65514.
9. Bazan NG (2007) Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care 10:136-141.
10. Berger GE, Proffitt TM, McConchie M, Yuen H, Wood SJ, Amminger GP, Brewer W, McGorry P.D. (2007) Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial. J Clin Psychiatry 68:1867-1875.
11. Bloch MH, Qawasmi A. (2011) Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry 50:991-1000.
12. Bondi CO, Taha AY, Tock JL, Totah NK, Cheon Y, Torres GE, Rapoport SI, Moghaddam B. (2014) Adolescent behavior and dopamine availability are uniquely sensitive to dietary omega-3 fatty acid deficiency. Biol Psychiatry 75:38-46.
13. Bos DJ, Oranje B, Veerhoek ES, Van Diepen RM, Weusten JM, Demmelmair H, Koletzko B, de Sain-van der Velden MG, Eilander A, Hoeksma M, Durston S (2015) Reduced symptoms of inattention after dietary omega-3 fatty acid supplementation in boys with and without attention deficit/hyperactivity disorder. Neuropsychopharmacology 40:2298-2306.
14. Boucher O, Burden MJ, Muckle G, Saint-Amour D, Ayotte P, Dewailly E, Nelson CA, Jacobson SW, Jacobson J.L. (2011) Neurophysiologic and neurobehavioral evidence of beneficial effects of prenatal omega-3 fatty acid intake on memory function at school age. Am J Clin Nutr 93:1025-1037.
15. Bradbury J, Myers SP, Oliver C. (2004) An adaptogenic role for omega-3 fatty acids in stress; a randomised placebo controlled double blind intervention study (pilot) [ISRCTN22569553]. Nutr J 3:20.
16. Burgess JR, Stevens L, Zhang W, Peck L. (2000) Long-chain polyun-saturated fatty acids in children with attention-deficit hyperactivity disorder. Am J Clin Nutr 71:327-330.
17. Cao D, Xue R, Xu J, Liu Z. (2005) Effects of docosahexaenoic acid on the survival and neurite outgrowth of rat cortical neurons in primary cultures. J Nutr Biochem 16:538-546.
18. Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Harris W.S. (2009) Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA 302:1651-1657.
19. Carrie I, Smirnova M, Clement M, De JD, Frances H, Bourre J.M. (2002) Docosahexaenoic acid-rich phospholipid supplementation: effect on behavior, learning ability, and retinal function in control and n-3 polyunsaturated fatty acid deficient old mice. Nutr Neurosci 5:43-52.
20. Cattaneo A, Macchi F, Plazzotta G, Veronica B, Bocchio-Chiavetto L, Riva MA, Pariante C.M. (2015) Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis. Front Cell Neurosci 9:40.
21. Chalon S, Delion-Vancassel S, Belzung C, Guilloteau D, Leguisquet AM, Besnard JC, Durand G. (1998) Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. J Nutr 128:2512-2519.
22. Childs CE, Romeu-Nadal M, Burdge GC, Calder P.C. (2008) Gender differences in the n-3 fatty acid content of tissues. Proc Nutr Soc 67:19-27.
23. Chiu CC, Su KP, Cheng TC, Liu HC, Chang CJ, Dewey ME, Stewart R, Huang S.Y. (2008) The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry 32:1538-1544.
24. Chung WL, Chen JJ, Su H.M. (2008) Fish oil supplementation of control and (n-3) fatty acid-deficient male rats enhances reference and working memory performance and increases brain regional docosahexaenoic acid levels. J Nutr 138:1165-1171.
25. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance G.W. (1980a) Extrauterine fatty acid accretion in infant brain: implications for fatty acid requirements. Early Hum Dev 4:131-138.
26. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance G.W. (1980b) Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev 4:121-129.
27. Cryan JF, Dinan T.G. (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13:701-712.
28. Cutuli D, De Bartolo P, Caporali P, Laricchiuta D, Foti F, Ronci M, Rossi C, Neri C, Spalletta G, Caltagirone C, Farioli-Vecchioli S, Petrosini L. (2014) n-3 polyunsaturated fatty acids supplementation enhances hippocampal functionality in aged mice. Front Aging Neurosci 6:220.
29. Dalton A, Wolmarans P, Witthuhn RC, van Stuijvenberg ME, Swanevelder SA, Smuts C.M. (2009) A randomised control trial in schoolchildren showed improvement in cognitive function after consuming a bread spread, containing fish flour from a marine source. Prostaglandins Leukot Essent Fatty Acids 80:143-149.
30. Dangour AD, Allen E, Elbourne D, Fasey N, Fletcher AE, Hardy P, Holder GE, Knight R, Letley L, Richards M, Uauy R. (2010) Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am J Clin Nutr 91:1725-1732.
31. Das UN (2006) Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J 1:420-439.
32. Davis PF, Ozias MK, Carlson SE, Reed GA, Winter MK, McCarson KE, Levant B. (2010) Dopamine receptor alterations in female rats with diet-induced decreased brain docosahexaenoic acid (DHA): interactions with reproductive status. Nutr Neurosci 13:161-169.
33. Delarue J, Matzinger O, Binnert C, Schneiter P, Chiolero R, Tappy L. (2003) Fish oil prevents the adrenal activation elicited by mental stress in healthy men. Diabetes Metab 29:289-295.
34. DeMar JC, Jr, Ma K, Bell JM, Igarashi M, Greenstein D, Rapoport SI (2006) One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J Lipid Res 47:172-180.
35. Dervola KS, Roberg BA, Woien G, Bogen IL, Sandvik TH, Sagvolden T, Drevon CA, Johansen EB, Walaas S.I. (2012) Marine Omicron-3 polyunsaturated fatty acids induce sex-specific changes in reinforcer-controlled behaviour and neurotransmitter metabolism in a spontaneously hypertensive rat model of ADHD. Behav Brain Funct 8:56.
36. Dinan TG, Cryan J.F. (2016) Mood by microbe: towards clinical translation. Genome Med 8:36.
37. Dyall SC, Michael GJ, Whelpton R, Scott AG, Michael-Titus AT (2007) Dietary enrichment with omega-3 polyunsaturated fatty acids reverses age-related decreases in the GluR2 and NR2B glutamate receptor subunits in rat forebrain. Neurobiol Aging 28:424-439.
38. Emsley R, Myburgh C, Oosthuizen P, van Rensburg SJ (2002) Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia. Am J Psychiatry 159:1596-1598.
39. Farooqui AA, Horrocks LA, Farooqui T. (2007) Modulation of inflammation in brain: a matter of fat. J Neurochem 101:577-599.
40. Fenton WS, Dickerson F, Boronow J, Hibbeln JR, Knable M. (2001) A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. Am J Psychiatry 158:2071-2074.
41. Ferraz AC, Delattre AM, Almendra RG, Sonagli M, Borges C, Araujo P, Andersen ML, Tufik S, Lima M.M. (2011) Chronic omega-3 fatty acids supplementation promotes beneficial effects on anxiety, cognitive and depressive-like behaviors in rats subjected to a restraint stress protocol. Behav Brain Res 219:116-122.
42. Florent S, Malaplate-Armand C, Youssef I, Kriem B, Koziel V, Escanye MC, Fifre A, Sponne I, Leininger-Muller B, Olivier JL, Pillot T, Oster T. (2006) Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-beta oligomers. J Neurochem 96:385-395.
43. Fontani G, Corradeschi F, Felici A, Alfatti F, Migliorini S, Lodi L. (2005) Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest 35:691-699.
44. Frangou S, Lewis M, McCrone P. (2006) Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised doubleblind placebo-controlled study. Br J Psychiatry 188:46-50.
45. Frangou S, Lewis M, Wollard J, Simmons A. (2007) Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder. J Psychopharmacol 21:435-439.
46. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace N.R. (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104:13780-13785.
47. Freund-Levi Y, Basun H, Cederholm T, Faxen-Irving G, Garlind A, Grut M, Vedin I, Palmblad J, Wahlund LO, Eriksdotter-Jonhagen M (2008) Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. Int J Geriatr Psychiatry 23:161-169.
48. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J. (2006) Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol 63:1402-1408.
49. Gainetdinov RR, Mohn AR, Bohn LM, Caron M.G. (2001) Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proc Natl Acad Sci U S A 98:11047-11054.
50. Gamoh S, Hashimoto M, Hossain S, Masumura S. (2001) Chronic administration of docosahexaenoic acid improves the performance of radial arm maze task in aged rats. Clin Exp Pharmacol Physiol 28:266-270.
51. Garcia-Calatayud S, Redondo C, Martin E, Ruiz JI, Garcia-Fuentes M, Sanjurjo P. (2005) Brain docosahexaenoic acid status and learning in young rats submitted to dietary long-chain poly-unsaturated fatty acid deficiency and supplementation limited to lactation. Pediatr Res 57:719-723.
52. Geleijnse JM, Giltay EJ, Kromhout D. (2012) Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients. Alzheimers Dement 8:278-287.
53. Gillies D, Sinn J, Lad SS, Leach MJ, Ross M.J. (2012) Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database Syst Rev 7:CD007986.
54. Grassmann V, Santos-Galduroz RF, Galduroz J.C. (2013) Effects of low doses of polyunsaturated fatty acids on the attention deficit/hyperactivity disorder of children: a systematic review. Curr Neuropharmacol 11:186-196.
55. Green KN, Martinez-Coria H, Khashwji H, Hall EB, Yurko-Mauro KA, Ellis L, LaFerla F.M. (2007) Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci 27:4385-4395.
56. Grenyer BF, Crowe T, Meyer B, Owen AJ, Grigonis-Deane EM, Caputi P, Howe P.R. (2007) Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 31:1393-1396.
57. Grimm H, Mayer K, Mayser P, Eigenbrodt E. (2002) Regulatory potential of n-3 fatty acids in immunological and inflammatory processes. Br J Nutr 87:59-67.
58. Grundy T, Toben C, Jaehne EJ, Corrigan F, Baune B.T. (2014) Longterm omega-3 supplementation modulates behavior, hippocampal fatty acid concentration, neuronal progenitor proliferation and central TNF-alpha expression in 7 month old unchallenged mice. Front Cell Neurosci 8:399.
59. Hallahan B, Hibbeln JR, Davis JM, Garland M.R. (2007) Omega-3 fatty acid supplementation in patients with recurrent self-harm. Single-centre double-blind randomised controlled trial. Br J Psychiatry 190:118-122.
60. Hamazaki T, Sawazaki S, Itomura M, Asaoka E, Nagao Y, Nishimura N, Yazawa K, Kuwamori T, Kobayashi M. (1996) The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study. J Clin Invest 97:1129-1133.
61. Hashimoto M, Hossain S, Shimada T, Sugioka K, Yamasaki H, Fujii Y, Ishibashi Y, Oka J, Shido O. (2002) Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J Neurochem 81:1084-1091.
62. Hashimoto M, Hossain S, Tanabe Y, Kawashima A, Harada T, Yano T, Mizuguchi K, Shido O. (2009) The protective effect of dietary eicosapentaenoic acid against impairment of spatial cognition learning ability in rats infused with amyloid beta(1-40). J Nutr Biochem 20:965-973.
63. Hashimoto M, Tanabe Y, Fujii Y, Kikuta T, Shibata H, Shido O. (2005) Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. J Nutr 135:549-555.
64. Helland IB, Smith L, Saarem K, Saugstad OD, Drevon C.A. (2003) Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 111:e39-44.
65. Hibbeln JR (1998) Fish consumption and major depression. Lancet 351:1213.
66. Hibbeln JR (2002) Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord 69:15-29.
67. Hirayama S, Hamazaki T, Terasawa K. (2004) Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study. Eur J Clin Nutr 58:467-473.
68. Horrobin DF (2001) Phospholipid metabolism and depression: the possible roles of phospholipase A2 and coenzyme A-independent transacylase. Hum Psychopharmacol 16:45-52.
69. Ikemoto A, Ohishi M, Sato Y, Hata N, Misawa Y, Fujii Y, Okuyama H. (2001) Reversibility of n-3 fatty acid deficiency-induced alterations of learning behavior in the rat: level of n-6 fatty acids as another critical factor. J Lipid Res 42:1655-1663.
70. Innis SM (2007) Dietary (n-3) fatty acids and brain development. J Nutr 137:855-859.
71. Jackson PA, Deary ME, Reay JL, Scholey AB, Kennedy D.O. (2012a) No effect of 12 weeks' supplementation with 1 g DHA-rich or EPA-rich fish oil on cognitive function or mood in healthy young adults aged 18-35 years. Br J Nutr 107:1232-1243.
72. Jackson PA, Reay JL, Scholey AB, Kennedy D.O. (2012b) Docosahexaenoic acid-rich fish oil modulates the cerebral hemodynamic response to cognitive tasks in healthy young adults. Biol Psychol 89:183-190.
73. Jensen CL, Voigt RG, Prager TC, Zou YL, Fraley JK, Rozelle JC, Turcich MR, Llorente AM, Anderson RE, Heird W.C. (2005) Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants. Am J Clin Nutr 82:125-132.
74. Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, Wang W, Tang W, Tan Z, Shi J, Li L, Ruan B. (2015) Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun 48:186-194.
75. Joardar A, Sen AK, Das S. (2006) Docosahexaenoic acid facilitates cell maturation and beta-adrenergic transmission in astrocytes. J Lipid Res 47:571-581.
76. Johnson EJ, McDonald K, Caldarella SM, Chung HY, Troen AM, Snodderly D.M. (2008) Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutr Neurosci 11:75-83.
77. Johnson M, Ostlund S, Fransson G, Kadesjo B, Gillberg C. (2009) Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents. J Atten Disord 12:394-401.
78. Kang JX, Weylandt K.H. (2008) Modulation of inflammatory cytokines by omega-3 fatty acids. Subcell Biochem 49:133-143.
79. Karr JE, Grindstaff TR, Alexander J.E. (2012) Omega-3 polyunsaturated fatty acids and cognition in a college-aged population. Exp Clin Psychopharmacol 20:236-242.
80. Keck PE, Jr, Mintz J, McElroy SL, Freeman MP, Suppes T, Frye MA, Altshuler LL, Kupka R, Nolen WA, Leverich GS, Denicoff KD, Grunze H, Duan N, Post RM (2006) Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry 60:1020-1022.
81. Kelly L, Grehan B, Chiesa AD, O'Mara SM, Downer E, Sahyoun G, Massey KA, Nicolaou A, Lynch M.A. (2011) The polyunsaturated fatty acids, EPA and DPA exert a protective effect in the hippocampus of the aged rat. Neurobiol Aging 32:2318 e2311-2315.
82. Kennedy DO, Jackson PA, Elliott JM, Scholey AB, Robertson BC, Greer J, Tiplady B, Buchanan T, Haskell C.F. (2009) Cognitive and mood effects of 8 weeks' supplementation with 400 mg or 1000 mg of the omega-3 essential fatty acid docosahexaenoic acid (DHA) in healthy children aged 10-12 years. Nutr Neurosci 12:48-56.
83. Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Glaser R. (2011) Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial. Brain Behav Immun 25:1725-1734.
84. Kirby A, Woodward A, Jackson S, Wang Y, Crawford M.A. (2010) A double-blind, placebo-controlled study investigating the effects of omega-3 supplementation in children aged 8-10 years from a mainstream school population. Res Dev Disabil 31:718-730.
85. Koletzko B, Cetin I, Brenna JT, Perinatal Lipid Intake Working Group; Child Health Foundation; Diabetic Pregnancy Study Group; European Association of Perinatal Medicine; European Association of Perinatal Medicine; European Society for Clinical Nutrition and Metabolism; European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Committee on Nutrition; International Federation of Placenta Associations; International Society for the Study of Fatty Acids and Lipids (2007) Dietary fat intakes for pregnant and lactating women. Br J Nutr 98:873-877.
86. Kotani S, Sakaguchi E, Warashina S, Matsukawa N, Ishikura Y, Kiso Y, Sakakibara M, Yoshimoto T, Guo J, Yamashima T. (2006) Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res 56:159-164.
87. Kram ML, Kramer GL, Ronan PJ, Steciuk M, Petty F. (2002) Dopamine receptors and learned helplessness in the rat: an autoradiographic study. Prog Neuropsychopharmacol Biol Psychiatry 26:639-645.
88. Kuratko CN, Barrett EC, Nelson EB, Salem N, Jr (2013) The relationship of docosahexaenoic acid (DHA) with learning and behavior in healthy children: a review. Nutrients 5:2777-2810.
89. Larrieu T, Hilal LM, Fourrier C, De Smedt-Peyrusse V, Sans N, Capuron L, Laye S (2014) Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion. Transl Psychiatry 4:e437.
90. Larrieu T, Hilal ML, De Smedt-Peyrusse V, Sans N, Laye S (2016) Nutritional omega-3 deficiency alters glucocorticoid receptor-signaling pathway and neuronal morphology in regionally distinct brain structures associated with emotional deficits. Neural Plast 2016:8574830.
91. Larrieu T, Madore C, Joffre C, Laye S. (2012) Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice. J Physiol Biochem 68:671-681.
92. Lee BH, Kim Y.K. (2010) The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment. Psychiatry Investig 7:231-235.
93. Lee LK, Shahar S, Chin AV, Yusoff N.A. (2013) Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial. Psychopharmacology (Berl) 225:605-612.
94. Lei X, Zhang W, Liu T, Xiao H, Liang W, Xia W, Zhang J. (2013) Perinatal supplementation with omega-3 polyunsaturated fatty acids improves sevoflurane-induced neurodegeneration and memory impairment in neonatal rats. PLoS One 8:e70645.
95. Levant B, Radel JD, Carlson S.E. (2004) Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Behav Brain Res 152:49-57.
96. Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O, Salem N Jr, Frautschy SA, Cole G.M. (2005a) A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 25:3032-3040.
97. Lim SY, Hoshiba J, Moriguchi T, Salem N Jr (2005b) N-3 fatty acid deficiency induced by a modified artificial rearing method leads to poorer performance in spatial learning tasks. Pediatr Res 58:741-748.
98. Lin PY, Huang SY, Su K.P. (2010) A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry 68:140-147.
99. Logan AC (2003) Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression. Altern Med Rev 8:410-425.
100. Logan AC, Jacka F.N. (2014) Nutritional psychiatry research: an emerging discipline and its intersection with global urbanization, environmental challenges and the evolutionary mismatch. J Physiol Anthropol 33:22.
101. Lucas M, Asselin G, Merette C, Poulin MJ, Dodin S. (2009) Ethyleicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial. Am J Clin Nutr 89:641-651.
102. Lynch AM, Loane DJ, Minogue AM, Clarke RM, Kilroy D, Nally RE, Roche OJ, O'Connell F, Lynch M.A. (2007) Eicosapentaenoic acid confers neuroprotection in the amyloid-beta challenged aged hippocampus. Neurobiol Aging 28:845-855.
103. Marangell LB, Martinez JM, Zboyan HA, Kertz B, Kim HF, Puryear L.J. (2003) A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 160:996-998.
104. Marra CA, de Alaniz MJ (1989) Influence of testosterone administration on the biosynthesis of unsaturated fatty acids in male and female rats. Lipids 24:1014-1019.
105. Mathieu G, Denis S, Langelier B, Denis I, Lavialle M, Vancassel S. (2010) DHA enhances the noradrenaline release by SH-SY5Y cells. Neurochem Int 56:94-100.
106. McEwen BS (2007) Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 87:873-904.
107. McNamara RK, Able J, Jandacek R, Rider T, Tso P, Eliassen JC, Alfieri D, Weber W, Jarvis K, DelBello MP, Strakowski SM, Adler C.M. (2010a) Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study. Am J Clin Nutr 91:1060-1067.
108. McNamara RK, Carlson S.E. (2006) Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids 75:329-349.
109. McNamara RK, Hahn CG, Jandacek R, Rider T, Tso P, Stanford KE, Richtand N.M. (2007) Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry 62:17-24.
110. McNamara RK, Jandacek R, Rider T, Tso P, Cole-Strauss A, Lipton J.W. (2010b) Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: relationship with central serotonin turnover. Prostaglandins Leukot Essent Fatty Acids 83:185-191.
111. McNamara RK, Vannest JJ, Valentine C.J. (2015) Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: mechanisms and implications for psychopathology. World J Psychiatry 5:15-34.
112. Meneses A, Perez-Garcia G, Ponce-Lopez T, Tellez R, Gallegos-Cari A, Castillo C. (2011) Spontaneously hypertensive rat (SHR) as an animal model for ADHD: a short overview. Rev Neurosci 22:365-371.
113. Michaeli B, Berger MM, Revelly JP, Tappy L, Chiolero R. (2007) Effects of fish oil on the neuro-endocrine responses to an endotoxin challenge in healthy volunteers. Clin Nutr 26:70-77.
114. Milte CM, Sinn N, Buckley JD, Coates AM, Young RM, Howe P.R. (2011) Polyunsaturated fatty acids, cognition and literacy in children with ADHD with and without learning difficulties. J Child Health Care 15:299-311.
115. Mischoulon D, Freeman M.P. (2013) Omega-3 fatty acids in psychiatry. Psychiatr Clin North Am 36:15-23.
116. Mischoulon D, Nierenberg AA, Schettler PJ, Kinkead BL, Fehling K, Martinson MA, Hyman Rapaport M (2015) A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression. J Clin Psychiatry 76:54-61.
117. Molendi-Coste O, Legry V, Leclercq I.A. (2011) Why and how meet n-3 PUFA dietary recommendations? Gastroenterol Res Pract 2011:364040.
118. Moranis A, Delpech JC, De Smedt-Peyrusse V, Aubert A, Guesnet P, Lavialle M, Joffre C, Laye S (2012) Long term adequate n-3 polyunsaturated fatty acid diet protects from depressive-like behavior but not from working memory disruption and brain cytokine expression in aged mice. Brain Behav Immun 26:721-731.
119. Moreira JD, Knorr L, Ganzella M, Thomazi AP, de Souza CG, de Souza DG, Pitta CF, Mello e Souza T, Wofichuk S, Elisabetsky E, Vinade L, Perry ML, Souza DO (2010) Omega-3 fatty acids deprivation affects ontogeny of glutamatergic synapses in rats: relevance for behavior alterations. Neurochem Int 56:753-759.
120. Moriguchi T, Greiner RS, Salem N Jr (2000) Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem 75:2563-2573.
121. Moriguchi T, Salem N Jr (2003) Recovery of brain docosahexaenoate leads to recovery of spatial task performance. J Neurochem 87:297-309.
122. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, Aggarwal N, Schneider J. (2003) Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 60:940-946.
123. Muldoon MF, Ryan CM, Sheu L, Yao JK, Conklin SM, Manuck S.B. (2010) Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood. J Nutr 140:848-853.
124. Muthayya S, Eilander A, Transler C, Thomas T, van der Knaap HC, Srinivasan K, van Klinken BJ, Osendarp SJ, Kurpad AV (2009) Effect of fortification with multiple micronutrients and n-3 fatty acids on growth and cognitive performance in Indian schoolchildren: the CHAMPION (Children's Health and Mental Performance Influenced by Optimal Nutrition) Study. Am J Clin Nutr 89:1766-1775.
125. Narendran R, Frankle WG, Mason NS, Muldoon MF, Moghaddam B. (2012) Improved working memory but no effect on striatal vesicular monoamine transporter type 2 after omega-3 poly-unsaturated fatty acid supplementation. PLoS One 7:e46832.
126. Nemets B, Stahl Z, Belmaker R.H. (2002) Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 159:477-479.
127. Nemets H, Nemets B, Apter A, Bracha Z, Belmaker R.H. (2006) Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry 163:1098-1100.
128. Nilsson A, Radeborg K, Salo I, Bjorck I. (2012) Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study. Nutr J 11:99.
129. Nishikawa M, Kimura S, Akaike N. (1994) Facilitatory effect of docosahexaenoic acid on N-methyl-D-aspartate response in pyramidal neurones of rat cerebral cortex. J Physiol 475:83-93.
130. Osendarp SJ, Baghurst KI, Bryan J, Calvaresi E, Hughes D, Hussaini M, Karyadi SJ, van Klinken BJ, van der Knaap HC, Lukito W, Mikarsa W, Transler C, Wilson C, Group NS (2007) Effect of a 12-mo micronutrient intervention on learning and memory in well-nourished and marginally nourished school-aged children: 2 parallel, randomized, placebo-controlled studies in Australia and Indonesia. Am J Clin Nutr 86:1082-1093.
131. Paloyelis Y, Mehta MA, Faraone SV, Asherson P, Kuntsi J. (2012) Striatal sensitivity during reward processing in attention-defiicit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 51:722-732 e729.
132. Palsdottir V, Mansson JE, Blomqvist M, Egecioglu E, Olsson B. (2012) Long-term effects of perinatal essential fatty acid deficiency on anxiety-related behavior in mice. Behav Neurosci 126:361-369.
133. Parletta N, Cooper P, Gent DN, Petkov J, O'Dea K (2013) Effects of fish oil supplementation on learning and behaviour of children from Australian Indigenous remote community schools: a randomised controlled trial. Prostaglandins Leukot Essent Fatty Acids 89:71-79.
134. Peet M, Brind J, Ramchand CN, Shah S, Vankar G.K. (2001) Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizophr Res 49:243-251.
135. Peet M, Horrobin D.F. (2002) A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59:913-919.
136. Peet M, Horrobin DF, Group EEMS (2002) A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. J Psychiatr Res 36:7-18.
137. Portillo-Reyes V, Perez-Garcia M, Loya-Mendez Y, Puente A.E. (2014) Clinical significance of neuropsychological improvement after supplementation with omega-3 in 8-12 years old malnourished Mexican children: a randomized, double-blind, placebo and treatment clinical trial. Res Dev Disabil 35:861-870.
138. Pusceddu MM, El Aidy S, Crispie F, O'Sullivan O, Cotter P, Stanton C, Kelly P, Cryan JF, Dinan T.G. (2015a) N-3 polyunsaturated fatty acids (PUFAs) reverse the impact of early-life stress on the gut microbiota. PLoS One 10:e0139721.
139. Pusceddu MM, Kelly P, Ariffin N, Cryan JF, Clarke G, Dinan T.G. (2015b) n-3 PUFAs have beneficial effects on anxiety and cognition in female rats: Effects of early life stress. Psychoneuroendocrinology 58:79-90.
140. Pusceddu MM, Nolan YM, Green HF, Robertson RC, Stanton C, Kelly P, Cryan JF, Dinan T.G. (2015c) The omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA) reverses corticosterone-induced changes in cortical neurons. Int J Neuropsychopharmacol. Advance online publication. doi:10.1093/ijnp/pyv130.
141. Rao JS, Ertley RN, Lee HJ, DeMar JC Jr, Arnold JT, Rapoport SI, Bazinet R.P. (2007) n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol Psychiatry 12:36-46.
142. Richardson AJ (2004) Long-chain polyunsaturated fatty acids in childhood developmental and psychiatric disorders. Lipids 39:1215-1222.
143. Richardson AJ, Burton JR, Sewell RP, Spreckelsen TF, Montgomery P. (2012) Docosahexaenoic acid for reading, cognition and behavior in children aged 7-9 years: a randomized, controlled trial (the DOLAB Study). PLoS One 7:e43909.
144. Richardson AJ, Calvin CM, Clisby C, Schoenheimer DR, Montgomery P, Hall JA, Hebb G, Westwood E, Talcott JB, Stein J.F. (2000) Fatty acid deficiency signs predict the severity of reading and related difficulties in dyslexic children. Prostaglandins Leukot Essent Fatty Acids 63:69-74.
145. Richardson AJ, Montgomery P. (2005) The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics 115:1360-1366.
146. Richardson AJ, Puri B.K. (2002) A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuropsychopharmacol Biol Psychiatry 26:233-239.
147. Richardson AJ, Ross M.A. (2000) Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot Essent Fatty Acids 63:1-9.
148. Robertson RC, Seira Oriach C, Murphy K, Moloney GM, Cryan JF, Dinan TG, Paul Ross R, Stanton C. (2016) Omega-3 polyunsaturated fatty acids critically regulate behaviour and gut microbiota development in adolescence and adulthood. Brain Behav Immun.
149. Rogers PJ, Appleton KM, Kessler D, Peters TJ, Gunnell D, Hayward RC, Heatherley SV, Christian LM, McNaughton SA, Ness A.R. (2008) No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. Br J Nutr 99:421-431.
150. Schlogelhofer M, Amminger GP, Schaefer MR, Fusar-Poli P, Smesny S, McGorry P, Berger G, Mossaheb N. (2014) Polyunsaturated fatty acids in emerging psychosis: a safer alternative? Early Interv Psychiatry 8:199-208.
151. Silvers KM, Woolley CC, Hamilton FC, Watts PM, Watson R.A. (2005) Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression. Prostaglandins Leukot Essent Fatty Acids 72:211-218.
152. Singh M (2005) Essential fatty acids, DHA and human brain. Indian J Pediatr 72:239-242.
153. Sinn N, Bryan J. (2007) Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD. J Dev Behav Pediatr 28:82-91.
154. Sinn N, Bryan J, Wilson C. (2008) Cognitive effects of polyunsaturated fatty acids in children with attention deficit hyperactivity disorder symptoms: a randomised controlled trial. Prostaglandins Leukot Essent Fatty Acids 78:311-326.
155. Sinn N, Milte C, Howe P.R. (2010) Oiling the brain: a review of randomized controlled trials of omega-3 fatty acids in psychopathology across the lifespan. Nutrients 2:128-170.
156. Sinn N, Milte CM, Street SJ, Buckley JD, Coates AM, Petkov J, Howe P.R. (2012) Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial. Br J Nutr 107:1682-1693.
157. Smuts CM, Huang M, Mundy D, Plasse T, Major S, Carlson S.E. (2003) A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol 101:469-479.
158. Soderberg M, Edlund C, Kristensson K, Dallner G. (1991) Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 26:421-425.
159. Stecher B, Robbiani R, Walker AW, Westendorf AM, Barthel M, Kremer M, Chaffron S, Macpherson AJ, Buer J, Parkhill J, Dougan G, von Mering C, Hardt W.D. (2007) Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 5:2177-2189.
160. Stevens L, Zhang W, Peck L, Kuczek T, Grevstad N, Mahon A, Zentall SS, Arnold LE, Burgess J.R. (2003) EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids 38:1007-1021.
161. Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell L.B. (1999) Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 56:407-412.
162. Stonehouse W, Conlon CA, Podd J, Hill SR, Minihane AM, Haskell C, Kennedy D. (2013) DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial. Am J Clin Nutr 97:1134-1143.
163. Stough C, Downey L, Silber B, Lloyd J, Kure C, Wesnes K, Camfield D. (2012) The effects of 90-day supplementation with the omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population. Neurobiol Aging 33:824 e821-823.
164. Su KP, Huang SY, Chiu CC, Shen W.W. (2003) Omega-3 fatty acids in major depressive disorder. A preliminary doubleblind, placebo-controlled trial. Eur Neuropsychopharmacol 13:267-271.
165. Su KP, Huang SY, Chiu TH, Huang KC, Huang CL, Chang HC, Pariante C.M. (2008) Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 69:644-651.
166. Su KP, Huang SY, Peng CY, Lai HC, Huang CL, Chen YC, Aitchison KJ, Pariante C.M. (2010) Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels. Biol Psychiatry 67:550-557.
167. Su KP, Lai HC, Yang HT, Su WP, Peng CY, Chang JP, Chang HC, Pariante C.M. (2014) Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial. Biol Psychiatry 76:559-566.
168. Sublette ME, Ellis SP, Geant AL, Mann J.J. (2011) Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry 72:1577-1584.
169. Takeuchi T, Iwanaga M, Harada E. (2003) Possible regulatory mechanism of DHA-induced anti-stress reaction in rats. Brain Res 964:136-143.
170. Terano T, Fujishiro S, Ban T, Yamamoto K, Tanaka T, Noguchi Y, Tamura Y, Yazawa K, Hirayama T. (1999) Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases. Lipids 34 Suppl:S345-346.
171. Umezawa M, Ohta A, Tojo H, Yagi H, Hosokawa M, Takeda T. (1995) Dietary alpha-linolenate/linoleate balance influences learning and memory in the senescence-accelerated mouse (SAM). Brain Res 669:225-233.
172. Vakhapova V, Cohen T, Richter Y, Herzog Y, Korczyn A.D. (2010) Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dement Geriatr Cogn Disord 29:467-474.
173. van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Dullemeijer C, Olderikkert MG, Beekman AT, de Groot CP (2008a) Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology 71:430-438.
174. van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Hoefnagels WH, Beekman AT, de Groot LC (2008b) Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 88:706-713.
175. Vancassel S, Leman S, Hanonick L, Denis S, Roger J, Nollet M, Bodard S, Kousignian I, Belzung C, Chalon S. (2008) n-3 polyunsaturated fatty acid supplementation reverses stress-induced modifications on brain monoamine levels in mice. J Lipid Res 49:340-348.
176. Vines A, Delattre AM, Lima MM, Rodrigues LS, Suchecki D, Machado RB, Tufik S, Pereira SI, Zanata SM, Ferraz A.C. (2012) The role of 5-HT(1)A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: a possible antidepressant mechanism. Neuropharmacology 62:184-191.
177. Voigt RG, Llorente AM, Jensen CL, Fraley JK, Berretta MC, Heird W.C. (2001) A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J Pediatr 139:189-196.
178. Wang PY, Chen JJ, Su H.M. (2010) Docosahexaenoic acid supplementation of primary rat hippocampal neurons attenuates the neurotoxicity induced by aggregated amyloid beta protein(42) and up-regulates cytoskeletal protein expression. J Nutr Biochem 21:345-350.
179. Williams C, Birch EE, Emmett PM, Northstone K. (2001) Stereoacuity at age 3.5 y in children born full-term is associated with prenatal and postnatal dietary factors: a report from a population-based cohort study. Am J Clin Nutr 73:316-322.
180. Witte AV, Kerti L, Hermannstadter HM, Fiebach JB, Schreiber SJ, Schuchardt JP, Hahn A, Floel A. (2014) Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb Cortex 24:3059-3068.
181. Wu A, Ying Z, Gomez-Pinilla F (2008) Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience 155:751-759.
182. Wurtman RJ (2014) A nutrient combination that can affect synapse formation. Nutrients 6:1701-1710.
183. Yehuda S, Rabinovitz S, Carasso RL, Mostofsky D.I. (2002) The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol Aging 23:843-853.
184. Yehuda S, Rabinovtz S, Carasso RL, Mostofsky D.I. (1996) Essential fatty acids preparation (SR-3) improves Alzheimer's patients quality of life. Int J Neurosci 87:141-149.
185. Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, Blackwell A, Salem N Jr, Stedman M, Investigators M. (2010) Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 6:456-464.
186. Zanarini MC, Frankenburg F.R. (2003) omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiatry 160:167-169.